PetVivo Holdings, Inc. (PETV)
USD 0.63
(4.99%)
USD 0.63
(4.99%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 968.7 Thousand USD | 5.62% |
| 2023 | 917.16 Thousand USD | 693.49% |
| 2022 | 115.58 Thousand USD | 818.95% |
| 2021 | 12.57 Thousand USD | 250.56% |
| 2020 | 3588.00 USD | -95.4% |
| 2019 | 77.93 Thousand USD | 5061.32% |
| 2018 | 1510.00 USD | -78.8% |
| 2017 | 7124.00 USD | -90.5% |
| 2016 | 75 Thousand USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 968.7 Thousand USD | 5.62% |
| 2024 Q1 | 117.18 Thousand USD | -6.7% |
| 2024 Q2 | 207.36 Thousand USD | 76.96% |
| 2024 Q4 | 48.26 Thousand USD | -91.9% |
| 2024 Q3 | 595.89 Thousand USD | 187.36% |
| 2023 Q4 | 125.59 Thousand USD | -75.38% |
| 2023 Q3 | 510.1 Thousand USD | 128.46% |
| 2023 Q2 | 223.28 Thousand USD | 283.81% |
| 2023 Q1 | 58.17 Thousand USD | 4.89% |
| 2023 FY | 917.16 Thousand USD | 693.49% |
| 2022 Q2 | 4977.00 USD | 20.07% |
| 2022 FY | 115.58 Thousand USD | 818.95% |
| 2022 Q1 | 4145.00 USD | -21.42% |
| 2022 Q3 | 51 Thousand USD | 924.79% |
| 2022 Q4 | 55.46 Thousand USD | 8.74% |
| 2021 Q2 | 4790.00 USD | 138.78% |
| 2021 Q1 | 2006.00 USD | -35.04% |
| 2021 FY | 12.57 Thousand USD | 250.56% |
| 2021 Q3 | 507.00 USD | -89.42% |
| 2021 Q4 | 5275.00 USD | 940.43% |
| 2020 FY | 3588.00 USD | -95.4% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q2 | 7690.00 USD | 0.0% |
| 2020 Q3 | 500.00 USD | -93.5% |
| 2020 Q4 | 3088.00 USD | 517.6% |
| 2019 Q1 | - USD | 100.0% |
| 2019 Q4 | 77.93 Thousand USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | 77.93 Thousand USD | 5061.32% |
| 2018 FY | 1510.00 USD | -78.8% |
| 2018 Q4 | -2163.00 USD | -200.0% |
| 2018 Q3 | 2163.00 USD | 561.47% |
| 2018 Q1 | 1183.00 USD | 2528.89% |
| 2018 Q2 | 327.00 USD | -72.36% |
| 2017 FY | 7124.00 USD | -90.5% |
| 2017 Q1 | 2009.00 USD | 0.0% |
| 2017 Q4 | 45.00 USD | -97.92% |
| 2017 Q3 | 2163.00 USD | -25.59% |
| 2017 Q2 | 2907.00 USD | 44.7% |
| 2016 Q1 | 75 Thousand USD | 0.0% |
| 2016 FY | 75 Thousand USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | -100.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acutus Medical, Inc. | 7.16 Million USD | 86.478% |
| Biotricity, Inc. | 12.06 Million USD | 91.97% |
| Cell MedX Corp. | - USD | -Infinity% |
| Dynatronics Corporation | 32.53 Million USD | 97.022% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -1157.341% |
| RetinalGenix Technologies Inc. | - USD | -Infinity% |
| Sonendo, Inc. | 43.86 Million USD | 97.792% |
| Telesis Bio, Inc. | 27.5 Million USD | 96.479% |
| Talis Biomedical Corporation | 412 Thousand USD | -135.123% |
| Viveve Medical, Inc. | 6.42 Million USD | 84.925% |